AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
--
--(--)
AXSM fundamentals
During Q4 2025, Axsome Therapeutics (AXSM) reported revenue of 196.00M, a YoY change of 65.03%. Net income was -28.56M, a YoY change of 61.88%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 8.82M -- | 16.85M -- | 24.37M -- | 94.58M -- | 46.70M +429.48% | 57.79M +243.07% | 71.53M +193.50% | 75.00M -20.70% | 87.17M +86.65% | 104.76M +81.27% | 118.77M +66.04% | 121.46M +61.95% | 150.04M +72.13% | 170.99M +63.22% | 196.00M +65.03% | 638.50M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 8.82M -- | 16.85M -- | 24.37M -- | 94.58M -- | 46.70M +429.48% | 57.79M +243.07% | 71.53M +193.50% | 75.00M -20.70% | 87.17M +86.65% | 104.76M +81.27% | 118.77M +66.04% | 121.46M +61.95% | 150.04M +72.13% | 170.99M +63.22% | 196.00M +65.03% | 638.50M -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 983.00K -- | 1.92M -- | 2.29M -- | 7.56M -- | 4.60M +367.85% | 6.53M +239.50% | 7.38M +222.04% | 6.30M -16.66% | 8.05M +75.15% | 8.44M +29.16% | 10.51M +42.50% | 9.79M +55.45% | 13.45M +66.95% | 11.91M +41.19% | 12.33M +17.26% | 47.48M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 5.20M -- | -- -- | -- -- | 6.53M -- | 7.38M +41.94% | 6.30M -- | 8.05M -- | 8.44M +29.16% | 10.51M +42.50% | 9.79M +55.45% | 13.45M +66.95% | 11.91M +41.19% | 12.33M +17.26% | 47.48M -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 7.84M -- | 14.92M -- | 22.08M -- | 87.02M -- | 42.10M +437.21% | 51.26M +243.53% | 64.15M +190.54% | 68.70M -21.05% | 79.11M +87.91% | 96.33M +87.91% | 108.25M +68.74% | 111.67M +62.55% | 136.59M +72.66% | 159.08M +65.15% | 183.67M +69.67% | 591.02M -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 180.00K -- | -- -- | 1.41M -- | -- -- | -- -- | -- -- | -- -- | 8.10M -- | -- -- | 2.47M -- | -- -- |
Operating Expenses | 2.08M -- | 2.02M -- | 3.15M -- | 5.88M -- | 6.83M +227.48% | 7.21M +256.15% | 7.63M +141.73% | 7.67M +30.41% | 6.75M -1.12% | 6.30M -12.63% | 6.44M -15.49% | 7.16M -6.63% | 7.99M +18.35% | 8.24M +30.90% | 9.45M +46.65% | 10.42M +45.49% | 13.45M +68.32% | 18.95M +129.85% | 24.43M +158.49% | 32.49M +211.77% | 17.78M +32.20% | 21.13M +11.50% | 27.74M +13.57% | 27.84M -14.30% | 30.85M +73.51% | 33.41M +58.13% | 32.61M +17.53% | 38.29M +37.51% | 47.02M +52.42% | 57.33M +71.62% | 82.00M +151.47% | 93.39M +143.92% | 107.16M +127.91% | 113.56M +98.07% | 162.43M +98.09% | 137.39M +47.11% | 157.16M +46.66% | 158.95M +39.97% | 180.87M +11.35% | 168.66M +22.76% | 181.41M +15.43% | 205.19M +29.09% | 213.10M +17.82% | 768.36M -- |
Selling, General and Administrative Expenses | 456.41K -- | 499.42K -- | 946.62K -- | 1.36M -- | 1.53M +235.05% | 1.64M +228.19% | 1.82M +92.14% | 1.69M +24.34% | 1.74M +14.00% | 1.83M +11.43% | 1.95M +7.23% | 2.41M +42.91% | 2.44M +39.90% | 2.20M +20.61% | 2.30M +17.89% | 2.82M +16.91% | 2.45M +0.25% | 3.11M +41.27% | 5.22M +127.17% | 4.97M +76.34% | 7.24M +195.94% | 6.33M +103.47% | 10.36M +98.35% | 11.25M +126.32% | 16.34M +125.88% | 20.23M +219.47% | 18.83M +81.73% | 25.70M +128.51% | 32.09M +96.31% | 42.50M +110.11% | 63.10M +235.19% | 75.76M +194.75% | 80.52M +150.96% | 84.80M +99.52% | 88.42M +40.11% | 100.56M +32.73% | 105.14M +30.57% | 97.17M +14.59% | 114.88M +29.93% | 122.36M +21.68% | 131.87M +25.42% | 151.84M +56.26% | 170.90M +48.77% | 576.97M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 6.34M -- | -- -- | -- -- | -- -- | 7.21M +13.60% | -- -- | -- -- | -- -- | 9.35M +29.76% | -- -- | -- -- | -- -- | 13.60M +45.41% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Research and Development Expenses | 1.63M -- | 1.52M -- | 2.21M -- | 4.53M -- | 5.30M +225.35% | 5.57M +265.31% | 5.81M +163.00% | 5.99M +32.23% | 5.01M -5.49% | 4.47M -19.71% | 4.49M -22.61% | 4.75M -20.60% | 5.55M +10.85% | 6.04M +35.11% | 7.15M +59.13% | 7.60M +59.98% | 11.00M +98.24% | 15.84M +162.14% | 19.21M +168.56% | 27.52M +261.98% | 10.54M -4.18% | 14.80M -6.57% | 17.38M -9.48% | 16.60M -39.70% | 14.50M +37.56% | 13.18M -10.92% | 13.78M -20.73% | 12.59M -24.17% | 15.79M +8.89% | 14.88M +12.87% | 14.69M +6.61% | 17.79M +41.38% | 20.58M +30.33% | 28.77M +93.37% | 30.80M +109.64% | 36.83M +106.99% | 49.85M +142.23% | 45.39M +57.78% | 55.01M +78.57% | 44.78M +21.60% | 49.54M -0.63% | 40.16M -11.51% | 48.79M -11.30% | 183.28M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -860.00K -- | -42.00K -- | 4.20M -- | -162.00K -- | 6.05M +803.84% | -- -- | 43.21M +928.74% | -- -- | 2.16M -64.32% | 16.39M -- | 10.98M -74.58% | 1.51M -- | -- -- | 13.19M -19.56% | -6.59M -160.04% | -- -- |
Operating Income | -2.08M -- | -2.02M -- | -3.15M -- | -5.88M -- | -6.83M -227.48% | -7.21M -256.15% | -7.63M -141.73% | -7.67M -30.41% | -6.75M +1.12% | -6.30M +12.63% | -6.44M +15.49% | -7.16M +6.63% | -7.99M -18.35% | -8.24M -30.90% | -9.45M -46.65% | -10.42M -45.49% | -13.45M -68.32% | -18.95M -129.85% | -24.43M -158.49% | -32.49M -211.77% | -17.78M -32.20% | -21.13M -11.50% | -27.74M -13.57% | -27.84M +14.30% | -30.85M -73.51% | -33.41M -58.13% | -32.61M -17.53% | -38.29M -37.51% | -39.18M -27.01% | -42.41M -26.95% | -59.92M -83.75% | -6.37M +83.35% | -65.06M -66.04% | -62.12M -46.47% | -98.27M -64.01% | -67.28M -955.46% | -78.05M -19.97% | -62.62M -0.81% | -72.62M +26.11% | -56.98M +15.30% | -36.71M +52.96% | -46.11M +26.37% | -26.96M +62.88% | -166.76M -- |
Non-Operating Income (Loss) | -44.59K -- | -2.55M -- | -210.38K -- | 16.92K -- | 15.09K +133.84% | 13.22K +100.52% | 296.62K +240.99% | -323.01K -2008.57% | -333.58K -2310.59% | -136.12K -1129.73% | -986.38K -432.54% | 2.36M +829.91% | -291.32K +12.67% | -38.52K +71.71% | -146.70K +85.13% | -218.90K -109.28% | -314.00K -7.78% | -188.38K -389.10% | -378.81K -158.22% | 7.31K +103.34% | -548.16K -74.58% | -1.80M -854.48% | -1.42M -274.96% | -1.42M -19466.83% | -1.44M -162.06% | -1.48M +17.94% | -1.37M +3.69% | -1.34M +5.15% | -2.26M -57.12% | -2.41M -63.40% | -1.32M +3.29% | -2.26M -68.58% | -2.73M -20.96% | -757.00K +68.60% | -702.00K +46.94% | -1.08M +52.21% | -1.30M +52.42% | -1.98M -161.29% | -2.21M -214.81% | -2.43M -124.68% | -12.22M -840.65% | -1.12M +43.38% | -1.17M +46.97% | -16.94M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -646.00K -- | -- -- | -- -- | -- -- | 2.79M +532.04% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -44.59K -- | -2.55M -- | -210.38K -- | 16.92K -- | 15.09K +133.84% | 13.22K +100.52% | 429.05K +303.94% | -323.01K -2008.57% | -333.58K -2310.59% | -136.12K -1129.73% | 999.82K +133.03% | 2.36M +829.91% | -291.32K +12.67% | -38.52K +71.71% | -1.81M -281.07% | -218.90K -109.28% | -314.00K -7.78% | -188.38K -389.10% | 860.72K +147.54% | 7.31K +103.34% | -548.16K -74.58% | -1.80M -854.48% | 1.15M +33.08% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | -10.38M -- | 0 -- | 0 -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 132.42K -- | -- -- | -- -- | -- -- | 1.34M +912.05% | -- -- | -- -- | -- -- | 1.13M -15.89% | -- -- | -- -- | -- -- | 1.24M +9.96% | -- -- | -- -- | -- -- | 2.57M +107.00% | 1.42M -- | 1.44M -- | 1.48M -- | 1.37M -46.68% | 1.34M -5.15% | 2.26M +57.12% | 2.41M +63.40% | 1.32M -3.29% | 2.26M +68.58% | 2.73M +20.96% | 757.00K -68.60% | 702.00K -46.94% | 1.08M -52.21% | 1.30M -52.42% | 1.98M +161.29% | 2.21M +214.81% | 2.43M +124.68% | 1.83M +41.19% | 1.12M -43.38% | 1.17M -46.97% | 6.56M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 132.42K -- | -- -- | -- -- | -- -- | 1.34M +912.05% | -- -- | -- -- | -- -- | 1.13M -15.89% | -- -- | -- -- | -- -- | 1.24M +9.96% | -- -- | -- -- | -- -- | -- -- | 1.42M -- | 1.44M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -2.13M -- | -4.58M -- | -3.36M -- | -5.87M -- | -6.81M -219.91% | -7.19M -57.22% | -7.33M -117.80% | -8.00M -36.30% | -7.08M -3.99% | -6.43M +10.58% | -7.43M -1.39% | -4.81M +39.89% | -8.28M -16.89% | -8.28M -28.73% | -9.60M -29.16% | -10.64M -121.42% | -13.76M -66.19% | -19.14M -131.05% | -24.81M -158.49% | -32.48M -205.29% | -18.33M -33.17% | -22.92M -19.80% | -29.16M -17.57% | -29.26M +9.93% | -32.28M -76.16% | -34.88M -52.16% | -33.98M -16.50% | -39.63M -35.45% | -41.44M -28.35% | -44.82M -28.50% | -61.24M -80.25% | -8.64M +78.20% | -67.79M -63.59% | -62.88M -40.28% | -98.98M -61.62% | -68.36M -691.35% | -79.34M -17.05% | -64.60M -2.74% | -74.83M +24.40% | -59.41M +13.08% | -48.93M +38.33% | -47.23M +26.89% | -28.13M +62.41% | -183.70M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | 2.58M -- | -617.00K -- | -678.00K -- | -325.00K -- | -- -- | -- -- | 0 +100.00% | 85.00K +126.15% | -- -- | -960.00K -- | 0 -- | 430.00K +405.88% | -- -- |
Net Income | -2.13M -- | -4.58M -- | -3.36M -- | -5.87M -- | -6.81M -219.91% | -7.19M -57.22% | -7.33M -117.80% | -8.00M -36.30% | -7.08M -3.99% | -6.43M +10.58% | -7.43M -1.39% | -4.81M +39.89% | -8.28M -16.89% | -8.28M -28.73% | -9.60M -29.16% | -10.64M -121.42% | -13.76M -66.19% | -19.14M -131.05% | -24.81M -158.49% | -32.48M -205.29% | -18.33M -33.17% | -22.92M -19.80% | -29.16M -17.57% | -29.26M +9.93% | -32.28M -76.16% | -34.88M -52.16% | -33.98M -16.50% | -39.63M -35.45% | -41.44M -28.35% | -44.82M -28.50% | -61.24M -80.25% | -11.22M +71.69% | -67.17M -62.10% | -62.20M -38.77% | -98.65M -61.09% | -68.36M -509.35% | -79.34M -18.13% | -64.60M -3.86% | -74.91M +24.06% | -59.41M +13.08% | -47.97M +39.54% | -47.23M +26.89% | -28.56M +61.88% | -183.17M -- |
Net Income Attributable to Owners of the Company | -2.13M -- | -4.58M -- | -3.36M -- | -5.87M -- | -6.81M -219.91% | -7.19M -57.22% | -7.33M -117.80% | -8.00M -36.30% | -7.08M -3.99% | -6.43M +10.58% | -7.43M -1.39% | -4.81M +39.89% | -8.28M -16.89% | -8.28M -28.73% | -9.60M -29.16% | -10.64M -121.42% | -13.76M -66.19% | -19.14M -131.05% | -24.81M -158.49% | -32.48M -205.29% | -18.33M -33.17% | -22.92M -19.80% | -29.16M -17.57% | -29.26M +9.93% | -32.28M -76.16% | -34.88M -52.16% | -33.98M -16.50% | -39.63M -35.45% | -41.44M -28.35% | -44.82M -28.50% | -61.24M -80.25% | -11.22M +71.69% | -67.17M -62.10% | -62.20M -38.77% | -98.65M -61.09% | -68.36M -509.35% | -79.34M -18.13% | -64.60M -3.86% | -74.91M +24.06% | -59.41M +13.08% | -47.97M +39.54% | -47.23M +26.89% | -28.56M +61.88% | -183.17M -- |
Net Income Attributable to Common Stockholders | -2.13M -- | -4.58M -- | -3.36M -- | -5.87M -- | -6.81M -219.91% | -7.19M -57.22% | -7.33M -117.80% | -8.00M -36.30% | -7.08M -3.99% | -6.43M +10.58% | -7.43M -1.39% | -4.81M +39.89% | -8.28M -16.89% | -8.28M -28.73% | -9.60M -29.16% | -10.64M -121.42% | -13.76M -66.19% | -19.14M -131.05% | -24.81M -158.49% | -32.48M -205.29% | -18.33M -33.17% | -22.92M -19.80% | -29.16M -17.57% | -29.26M +9.93% | -32.28M -76.16% | -34.88M -52.16% | -33.98M -16.50% | -39.63M -35.45% | -41.44M -28.35% | -44.82M -28.50% | -61.24M -80.25% | -11.22M +71.69% | -67.17M -62.10% | -62.20M -38.77% | -98.65M -61.09% | -68.36M -509.35% | -79.34M -18.13% | -64.60M -3.86% | -74.91M +24.06% | -59.41M +13.08% | -47.97M +39.54% | -47.23M +26.89% | -28.56M +61.88% | -183.17M -- |
Other Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -67.17M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -27.20M -- | -- -- | -- -- | -- -- | -28.94M -6.40% | -- -- | -- -- | -- -- | -30.97M -6.99% | -- -- | -- -- | -- -- | -68.35M -120.71% | -- -- | -- -- | -- -- | -102.90M -50.56% | -- -- | -- -- | -- -- | -130.40M -26.73% | -- -- | -- -- | -- -- | -187.13M -43.50% | -- -- | -67.17M -- | -62.20M -- | -98.65M +47.28% | -68.36M -- | -79.34M -18.13% | -64.60M -3.86% | -74.91M +24.06% | -59.41M +13.08% | -47.97M +39.54% | -47.23M +26.89% | -28.56M +61.88% | -183.17M -- |
Basic EPS | -0.19 -- | -0.41 -- | -- -- | -0.31 -- | -0.36 -89.47% | -0.38 +7.32% | -0.38 -- | -0.41 -32.26% | -0.3 +16.67% | -0.27 +28.95% | -0.29 +23.68% | -0.19 +53.66% | -0.32 -6.67% | -0.31 -14.81% | -0.32 -10.34% | -0.32 -68.42% | -0.41 -28.12% | -0.56 -80.65% | -0.67 -109.38% | -0.88 -175.00% | -0.49 -19.51% | -0.61 -8.93% | -0.78 -16.42% | -0.78 +11.36% | -0.86 -75.51% | -0.93 -52.46% | -0.9 -15.38% | -1.03 -32.05% | -1.06 -23.26% | -1.07 -15.05% | -1.41 -56.67% | -0.26 +74.76% | -1.54 -45.28% | -1.32 -23.36% | -2.08 -47.52% | -1.44 -453.85% | -1.67 -8.44% | -1.34 -1.52% | -1.54 +25.96% | -1.22 +15.28% | -0.97 +41.92% | -0.94 +29.85% | -0.56 +63.64% | -3.69 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.32 -- | -- -- | -1.44 -- | -1.67 -- | -1.34 -1.52% | -- -- | -1.22 +15.28% | -0.97 +41.92% | -0.94 +29.85% | -- -- | -- -- |
Diluted EPS | -0.19 -- | -0.41 -- | -- -- | -0.31 -- | -0.36 -89.47% | -0.38 +7.32% | -- -- | -0.41 -32.26% | -0.3 +16.67% | -0.27 +28.95% | -- -- | -0.19 +53.66% | -0.32 -6.67% | -0.31 -14.81% | -- -- | -0.32 -68.42% | -0.41 -28.12% | -0.56 -80.65% | -- -- | -0.88 -175.00% | -0.49 -19.51% | -0.61 -8.93% | -- -- | -0.78 +11.36% | -0.86 -75.51% | -0.93 -52.46% | -- -- | -1.03 -32.05% | -1.06 -23.26% | -1.07 -15.05% | -- -- | -0.26 +74.76% | -1.54 -45.28% | -1.32 -23.36% | -- -- | -1.44 -453.85% | -1.67 -8.44% | -1.34 -1.52% | -- -- | -1.22 +15.28% | -0.97 +41.92% | -0.94 +29.85% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.32 -- | -- -- | -1.44 -- | -1.67 -- | -1.34 -1.52% | -- -- | -1.22 +15.28% | -0.97 +41.92% | -0.94 +29.85% | -- -- | -- -- |
You can ask Aime
What factors drove the changes in Axsome Therapeutics's revenue and profit?What were the key takeaways from Axsome Therapeutics's earnings call?What is the market's earnings forecast for Axsome Therapeutics next quarter?Did Axsome Therapeutics beat or miss consensus estimates last quarter?What is Axsome Therapeutics's gross profit margin?What is Axsome Therapeutics's latest dividend and current dividend yield?What guidance did Axsome Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Axsome Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
